Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Phase I results for rectally administered microbicide gel formulated with IQP-0528

March 12, 2020

Safety and PK data presented for GS-9722

March 12, 2020

In SIV infection, gut integrity is retained, not repaired

March 12, 2020

Gilead presents 96-week data from DISCOVER trial of Descovy for PrEP

March 11, 2020

Broadly neutralizing antibody plus latency reversing treatment evaluated in HIV trial

March 11, 2020

Encouraging 48-week data from phase III ATLAS-2M study of long-acting HIV regimen

March 10, 2020

CROI in the time of COVID-19: Researchers phoning it in at all-virtual 2020 CROI

March 10, 2020

New phase III trials evaluate switch to doravirine/islatravir in HIV patients on other regimens

March 3, 2020

ViiV Healthcare presents new antivirals for HIV infection

Feb. 27, 2020

GlaxoSmithKline and ViiV Healthcare present compounds for HIV infection

Feb. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...